BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33145502)

  • 21. A multiparametric analysis based on DCE-MRI to improve the accuracy of parotid tumor discrimination.
    Xu Z; Zheng S; Pan A; Cheng X; Gao M
    Eur J Nucl Med Mol Imaging; 2019 Oct; 46(11):2228-2234. PubMed ID: 31372671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Basal cell adenoma of the parotid gland; MR features and differentiation from pleomorphic adenoma.
    Mukai H; Motoori K; Horikoshi T; Takishima H; Nagai Y; Okamoto Y; Uno T
    Dentomaxillofac Radiol; 2016; 45(4):20150322. PubMed ID: 26837669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiation of salivary gland tumor using diffusion-weighted imaging with a fractional order calculus model.
    Chen W; Zhu LN; Dai YM; Jiang JS; Bu SS; Xu XQ; Wu FY
    Br J Radiol; 2020 Sep; 93(1113):20200052. PubMed ID: 32649236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diffusion-weighted imaging with histogram analysis of the apparent diffusion coefficient maps in the diagnosis of parotid tumours.
    Abdel Razek AAK; Gadelhak BN; El Zahabey IA; Elrazzak GAEA; Mowafey B
    Int J Oral Maxillofac Surg; 2022 Feb; 51(2):166-174. PubMed ID: 33895039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative dynamic contrast-enhanced MRI and readout segmentation of long variable echo-trains diffusion-weighted imaging in differentiating parotid gland tumors.
    Huang N; Xiao Z; Chen Y; She D; Guo W; Yang X; Chen Q; Cao D; Chen T
    Neuroradiology; 2021 Oct; 63(10):1709-1719. PubMed ID: 34241661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-enhanced MRI in combination with color Doppler flow imaging for improving diagnostic accuracy of parotid gland lesions.
    Zhang W; Zuo Z; Luo N; Liu L; Jin G; Liu J; Su D
    Eur Arch Otorhinolaryngol; 2018 Apr; 275(4):987-995. PubMed ID: 29430614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histogram analysis of apparent diffusion coefficient maps for differentiating malignant from benign parotid gland tumors.
    Ma G; Zhu LN; Su GY; Hu H; Qian W; Bu SS; Xu XQ; Wu FY
    Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2151-2157. PubMed ID: 29961924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of Parotid Tumors With Dynamic Susceptibility Contrast Perfusion-Weighted Magnetic Resonance Imaging and Diffusion-Weighted MR Imaging.
    Abdel Razek AA; Samir S; Ashmalla GA
    J Comput Assist Tomogr; 2017 Jan; 41(1):131-136. PubMed ID: 27636248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diffusion-weighted echo-planar MRI: a valuable tool for differentiating primary parotid gland tumors?
    Habermann CR; Gossrau P; Graessner J; Arndt C; Cramer MC; Reitmeier F; Jaehne M; Adam G
    Rofo; 2005 Jul; 177(7):940-5. PubMed ID: 15973595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Added Value of Diffusion-Weighted Magnetic Resonance Imaging in Differentiating Musculoskeletal Tumors Using Sensitivity and Specificity: A Retrospective Study and Review of Literature.
    Boruah DK; Gogoi B; Patni RS; Sarma K; Hazarika K
    Cureus; 2021 Jan; 13(1):e12422. PubMed ID: 33542870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parotid Warthin's tumor: novel MR imaging score as diagnostic indicator.
    Luna LP; Coffey W; Alvin MD; Shanechi AM; Sankaran N; Rodriguez EF; Naeem Z; Aygun N; Khan M
    Clin Imaging; 2022 Jan; 81():9-14. PubMed ID: 34598007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diffusion weighted magnetic resonance imaging in the diagnosis of parotid masses. Preliminary results.
    Yologlu Z; Aydin H; Alp NA; Aribas BK; Kizilgoz V; Arda K
    Saudi Med J; 2016 Dec; 37(12):1412-1416. PubMed ID: 27874161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parotid gland tumors: can addition of diffusion-weighted MR imaging to dynamic contrast-enhanced MR imaging improve diagnostic accuracy in characterization?
    Yabuuchi H; Matsuo Y; Kamitani T; Setoguchi T; Okafuji T; Soeda H; Sakai S; Hatakenaka M; Nakashima T; Oda Y; Honda H
    Radiology; 2008 Dec; 249(3):909-16. PubMed ID: 18941162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of MRI-based radiomic features for distinguishing Warthin tumor from pleomorphic adenoma: performance assessment using T2-weighted and post-contrast T1-weighted MR images.
    Faggioni L; Gabelloni M; De Vietro F; Frey J; Mendola V; Cavallero D; Borgheresi R; Tumminello L; Shortrede J; Morganti R; Seccia V; Coppola F; Cioni D; Neri E
    Eur J Radiol Open; 2022; 9():100429. PubMed ID: 35757232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The value of high resolution diffusion weighted imaging in differentiating benign and malignant epithelial tumors of parotid gland].
    Wen BH; Cheng JL; Zhang HX; Zhang ZX; Wang FF; Xue KK
    Zhonghua Yi Xue Za Zhi; 2018 May; 98(17):1347-1351. PubMed ID: 29764037
    [No Abstract]   [Full Text] [Related]  

  • 36. Value of apparent diffusion coefficient calculation in the differential diagnosis of parotid gland tumors.
    Yerli H; Agildere AM; Aydin E; Geyik E; Haberal N; Kaskati T; Oguz D; Ozluoglu LN
    Acta Radiol; 2007 Nov; 48(9):980-7. PubMed ID: 17957512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of MR imaging findings differentiating parotid basal cell adenomas from other parotid tumors.
    Murayama Y; Kamitani T; Sagiyama K; Yamasaki Y; Hida T; Matsuura Y; Yasumatsu R; Yamamoto H; Yabuuchi H; Ishigami K
    Eur J Radiol; 2021 Nov; 144():109980. PubMed ID: 34601323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Texture-based and diffusion-weighted discrimination of parotid gland lesions on MR images at 3.0 Tesla.
    Fruehwald-Pallamar J; Czerny C; Holzer-Fruehwald L; Nemec SF; Mueller-Mang C; Weber M; Mayerhoefer ME
    NMR Biomed; 2013 Nov; 26(11):1372-9. PubMed ID: 23703801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Basal cell adenoma of the parotid gland: a clinicopathological study of nine cases--basal cell adenoma versus pleomorphic adenoma and Warthin's tumor.
    Kawata R; Yoshimura K; Lee K; Araki M; Takenaka H; Tsuji M
    Eur Arch Otorhinolaryngol; 2010 May; 267(5):779-83. PubMed ID: 19908055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perfusion Computed Tomography Scan Imaging in Differentiation of Benign from Malignant Parotid Lesions.
    Niazi M; Mohammadzadeh M; Aghazadeh K; Sharifian H; Karimi E; Shakiba M; Baniasadi M; Rahmaty B; Adel S; Moharreri M
    Int Arch Otorhinolaryngol; 2020 Apr; 24(2):e160-e169. PubMed ID: 32256836
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.